Literature DB >> 7686827

Hyperbaric oxygen treatment enhances the recovery of blood flow and functional capillary density in postischemic striated muscle.

A Sirsjö1, H A Lehr, D Nolte, T Haapaniemi, D H Lewis, G Nylander, K Messmer.   

Abstract

The effect of hyperbaric oxygen (HBO) at 2.5 atmospheres of absolute pressure (ATA) on postischemic reperfusion injury in striated muscle was studied using two different animal models. One used complete tourniquet ischemia (4 hr) in the rat hindlimb, measuring blood flow in the tibialis anterior muscle by the xenon washout method at 1-1.5 and 4.5-5 hr after the start of reperfusion. The other used 4 hr of pressure-induced ischemia in the fine striated skin muscle, contained within a dorsal skinfold chamber in hamsters. Vital fluorescence microscopy was employed to measure the functional capillary density using fluorescein isothiocyanate-dextran (mw 150,000) as a plasma marker. After 1-1.5 hr of reperfusion following 4 hr of total ischemia, postischemic blood flow was severely depressed, with no significant difference between the HBO-treated and the untreated rats. However, after 4.5-5 hr of reperfusion, blood flow rates in the postischemic muscle in the HBO-treated animals did not differ significantly from those in nonischemic muscle, compared to a persistent, significant depression in the untreated animals. No significant difference was seen in functional capillary density between HBO-treated and untreated hamsters following 1 hr of reperfusion. After 5 hr of reperfusion, capillary density was significantly improved in HBO-treated animals compared to untreated animals. These results suggest that HBO treatment enhances the recovery of blood flow and functional capillary density in postischemic muscle tissue, indicating attenuation of the microvascular dysfunction or damage in the postischemic period.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686827

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  8 in total

1.  Hyperbaric oxygen in systemic inflammatory response.

Authors:  Haim Bitterman; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2004-03-18       Impact factor: 17.440

2.  Effect of 100% oxygen on E-selectin expression, recruitment of neutrophils and enterocyte apoptosis following intestinal ischemia-reperfusion in a rat.

Authors:  Igor Sukhotnik; Arnold G Coran; Robert Greenblatt; Vera Brod; Jorge Mogilner; Eitan Shiloni; Ron Shaoul; Haim Bitterman
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

3.  Experimental models to study microcirculatory dysfunction in muscle ischemia-reperfusion and osteomyocutaneous flap transfer.

Authors:  Michael D Menger; Matthias W Laschke; Michaela Amon; Rene Schramm; Henrik Thorlacius; Martin Rücker; Brigitte Vollmar
Journal:  Langenbecks Arch Surg       Date:  2003-10-07       Impact factor: 3.445

Review 4.  Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.

Authors:  Jacob Bejar; Eli Peled; Jochanan H Boss
Journal:  Theor Biol Med Model       Date:  2005-07-05       Impact factor: 2.432

Review 5.  Bench-to-bedside review: oxygen as a drug.

Authors:  Haim Bitterman
Journal:  Crit Care       Date:  2009-02-24       Impact factor: 9.097

6.  A new in vivo model using a dorsal skinfold chamber to investigate microcirculation and angiogenesis in diabetic wounds.

Authors:  Stefan Langer; Christian Beescho; Andrej Ring; Olivia Dorfmann; Hans Ulrich Steinau; Nick Spindler
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2016-02-18

7.  Hyperbaric Oxygen Inhibits Reperfusion-Induced Neutrophil Polarization and Adhesion Via Plasmin-Mediated VEGF Release.

Authors:  Ashish Francis; Shawna R Kleban; Linda L Stephenson; Patrick S Murphy; Peter R Letourneau; Xin-Hua Fang; Wei Z Wang; Richard C Baynosa
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-09-25

Review 8.  Intracoronary Application of Super-Saturated Oxygen to Reduce Infarct Size Following Myocardial Infarction.

Authors:  Andreas Schäfer; Muharrem Akin; Johanna Diekmann; Tobias König
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.